Coronavirus (COVID - 19): Chemical Entities of Biological Interest
- 23 November 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 21 (17), 2497-2506
- https://doi.org/10.2174/1389557521666210125145700
Abstract
Virus, a sub-microscopic infectious agent that replicates only inside the living cells of a host causes viral infection. Currently the instant imperative is to control the combat against novel corona virus outbreak caused by COVID19 virus which started from China and spread all over the world. The ease of travel has emphasized COVID-19 virus prevention as a serious issue for the safety of human beings. Exponential rise in the number of corona patients is a matter of concern for governing bodies of various countries inspite of countless cooperative efforts put in by citizens, organizations and government. India is now among the top worst hit nation by the COVID-19 pandemic. The present article reviews stateof-art various medicinal approaches available that are presently used to control the spread of coronavirus pandemic.Keywords
Funding Information
- University Grants Commission (Ministry of Human Resource Development, Govt. of India) under UGCBSR Start-up grant (F.30-35/2017(BSR))
This publication has 51 references indexed in Scilit:
- The Cellular Interactome of the Coronavirus Infectious Bronchitis Virus Nucleocapsid Protein and Functional Implications for Virus BiologyJournal of Virology, 2013
- Molecular Dynamics Investigation on a Series of HIV Protease Inhibitors: Assessing the Performance of MM-PBSA and MM-GBSA ApproachesJournal of Chemical Information and Modeling, 2012
- On the free radical scavenging activities of melatonin's metabolites, AFMK and AMKJournal of Pineal Research, 2012
- Emodin inhibits current through SARS-associated coronavirus 3a proteinAntiviral Research, 2011
- Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibitionBioorganic & Medicinal Chemistry, 2010
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory MedicationsClinical Microbiology Reviews, 2010
- Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitisRespiratory Research, 2010
- Tocilizumab: The first interleukin-6-receptor inhibitorAmerican Journal of Health-System Pharmacy, 2008
- Survey of Dogs in Japan for Group 2 Canine Coronavirus InfectionJournal of Clinical Microbiology, 2006
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004